UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer.
Gilani RA, Phadke S, Bao LW, Lachacz EJ, Dziubinski ML, Brandvold KR, Steffey ME, Kwarcinski FE, Graveel CR, Kidwell KM, Merajver SD, Soellner MB.
Gilani RA, et al.
Clin Cancer Res. 2016 Oct 15;22(20):5087-5096. doi: 10.1158/1078-0432.CCR-15-2158. Epub 2016 May 6.
Clin Cancer Res. 2016.
PMID: 27154914
Retracted.